Simpor Pharma, Brunei’s first Halal pharmaceutical manufacturing company, has continued to make great strides forward, exporting its products abroad to multiple countries in Asia and North America, with an eye set on reaching even more markets, including the Middle East.
Simpor Pharma Sdn Bhd is a joint venture between Viva Pharmaceutical Inc of Canada and Strategic Development Capital Fund, one of Brunei’s private equity funds. With an investment value of over US$26 million, it is the country’s first Good Manufacturing Practice (GMP) and Halal-certified contract manufacturer of pharmaceuticals, nutraceuticals and cosmetic products.
More details in Tuesday’s Borneo Bulletin.
The post Simpor Pharma sets sight on Middle East market appeared first on Borneo Bulletin Online.